4Kagi D,Ho A,Odermall B. TNF receptor1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes[J].Journal of Immunology,1999,(08):4598-4605.
二级参考文献23
1[1]Tuomi T, Groop LC,Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease[J]. Diabetes. 1993,42(2):359-362.
2[2]Juneja R, Hirsch IB, Naik RG, et al. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1 ( 1/2 ) diabetes in patients presenting with type 2 diabetes [J].Metabolism, 2001,50(9):1008-1013.
3[4]Schiel R, Muller UA. GAD autoantibodies in a selectionfree population of insulin treated diabetic patients:indicator of a high prevalence of LADA[J]? Diabetes Res Clin Pract, 2000,49(1):33-40.
4[5]Desailloud R, Fajardy I,Vambergue A, et al. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes[J]. Diabetes Metab, 2000,26(5):353-360.
5[6]Lohmann T, Kellner K,Verlohren HJ, et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)[J].Diabetologia, 2001,44(8):1005-1010.
6Barone R, Procaccini E, Chianelli M, et al. Prognostic relevance of uptake of technetium-99m labeled human polyclonal immunoglobulin in the pancreas of patients with type 1 diabetes. Eur J Nucl Med, 1998,25: 503-508.
7Chianelli M, Signore A, Fritzberg AR, et al. The development of technetium -99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases. Nucl Med Biol, 1997,24:579-586.
8William EW, Harris N, Desmond S. Immunological markers in the diagnosis and prediction of autoimmune type 1a diabetes. Clinical Diabetes, 2002,20:183-191.
9Signore A, Chianelli M, Parisella MG, et al. In vivo imaging of insulitis in autoimmune diabetes. J Endocrinol Invest,1999,22:151-158.
10Signore A, Chianelli M, Annovazzi A, et al. 123I-labelled interleukin-2scintigraphy for the in vivo assesment of intestinal mononuclear cell infiltration in Crohn's disease. J Nucl Med,2000,41:242-249.
